Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hose

Showing results (11-20 of 189) with videos related to

Pageof 19
Sort By:
Acta Biomaterialia|July 15, 2019
Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cellsAnna Luise Grab, Anja Seckinger, Patrick Horn, et al.
Biochemical and Biophysical Research Communications|March 10, 2009
Embryonic stem cell markers expression in cancersMatthieu Schoenhals, Alboukadel Kassambara, John De Vos, et al.
Experimental Hematology|April 8, 2014
Immunomodulatory drugs thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitroArnold Bolomsky, Martin Schreder, Tobias Meißner, et al.
Experimental Hematology|September 22, 2010
MYEOV is a prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Amélie Bonnefond, et al.
Plos Computational Biology|January 31, 2015
GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cellsAlboukadel Kassambara, Thierry Rème, Michel Jourdan, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 31, 2017
Drug Release as a function of bioactivity, incubation regime, liquid, and initial load: Release of bortezomib from calcium phosphate-containing silica/collagen xerogelsBenjamin Kruppke, Dirk Hose, Reinhard Schnettler, et al.
British Journal of Cancer|February 12, 2016
Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myelomaElena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, et al.
Haematologica|April 16, 2013
Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myelomaMatthieu Schoenhals, Alboukadel Kassambara, Jean-Luc Veyrune, et al.
Journal of Chromatography. A|May 1, 2014
Stability of the proteasome inhibitor bortezomib in cell based assays determined by ultra-high performance liquid chromatography coupled to tandem mass spectrometryJannick Clemens, Magdalena Longo, Anja Seckinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myelomaMaud Condomines, Dirk Hose, Thierry Rème, et al.
Pageof 19

Showing results (11-20 of 189) with videos related to

Sort By:
Pageof 19
Acta Biomaterialia|July 15, 2019
Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cellsAnna Luise Grab, Anja Seckinger, Patrick Horn, et al.
Biochemical and Biophysical Research Communications|March 10, 2009
Embryonic stem cell markers expression in cancersMatthieu Schoenhals, Alboukadel Kassambara, John De Vos, et al.
Experimental Hematology|April 8, 2014
Immunomodulatory drugs thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitroArnold Bolomsky, Martin Schreder, Tobias Meißner, et al.
Experimental Hematology|September 22, 2010
MYEOV is a prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Amélie Bonnefond, et al.
Plos Computational Biology|January 31, 2015
GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cellsAlboukadel Kassambara, Thierry Rème, Michel Jourdan, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|May 31, 2017
Drug Release as a function of bioactivity, incubation regime, liquid, and initial load: Release of bortezomib from calcium phosphate-containing silica/collagen xerogelsBenjamin Kruppke, Dirk Hose, Reinhard Schnettler, et al.
British Journal of Cancer|February 12, 2016
Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myelomaElena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, et al.
Haematologica|April 16, 2013
Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myelomaMatthieu Schoenhals, Alboukadel Kassambara, Jean-Luc Veyrune, et al.
Journal of Chromatography. A|May 1, 2014
Stability of the proteasome inhibitor bortezomib in cell based assays determined by ultra-high performance liquid chromatography coupled to tandem mass spectrometryJannick Clemens, Magdalena Longo, Anja Seckinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myelomaMaud Condomines, Dirk Hose, Thierry Rème, et al.
Pageof 19